5 Obesity Readouts to Watch in the Second Half of 2024
09 Aug 2024 //
BIOSPACE
Aphaia Pharma Announces Positive Phase 2 Results For Prediabetes Treatment
20 Jun 2024 //
GLOBENEWSWIRE
Aphaia Pharma Completes Enrollment in Arm 2 of Phase 2 Trial for Obesity
13 Jun 2024 //
GLOBENEWSWIRE
Aphaia Provides Obesity Phase 2 Trial Update
25 Apr 2024 //
GLOBENEWSWIRE
Aphaia Pharma to Participate in Panel at 10th LSX World Congress
16 Apr 2024 //
GLOBENEWSWIRE
Aphaia Pharma Announces Dosing of First Patient in its Ph2 Trial
25 Apr 2023 //
GLOBENEWSWIRE